Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: Meta-analysis of randomized trials

Article Abstract:

A class-wide meta-analysis of randomized trials of cyclooxygenase 2 (COX-2) inhibitors including rofecoxib, celecoxib, valdecoxib, parecoxib, etoricoxib and lumiracoxib is conducted in order to comprehensively quantify adverse risks and potential drug class effect for renal outcomes and arrhythmia events. Results reveal that rofecoxib increases risk of renal events and arrhythmia events, although a class effect is not evident, thus necessitating a cumulative and active surveillance system to monitor treatments.

Author: Yiqing Song, Jingjing Zhang, Eric L. Ding
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Kidney diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2

Article Abstract:

A systematic review and meta-analysis of controlled observational studies is undertaken to compare the risks of serious cardiovascular events with individual nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase 2 inhibitors. The results confirm findings from randomized trials regarding the risk of cardiovascular events with rofecoxib, which suggest that celecoxib in commonly used doses, may not increase the risk.

Author: Henry, David, McGettigan, Patricia
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Heart & Cardiovascular R&D, Cardiovascular diseases, Cardiovascular research, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis

Article Abstract:

A study was undertaken to understand the connection between the risk of type 2 diabetes and plasma levels of testosterone, sex hormone-binding globulin (SHBG) and estradiol. The conclusion reveals that endogenous levels of testosterone and SHBG each exhibit sex-dependent relations with risk of type 2 diabetes warranting further study of sex specific etiologies of type 2 diabetes and the complications connected with it.

Author: Ding, Eric L., Yiqing Song, Malik, Vasanti S., Simin Liu
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Health aspects, Diabetics, Type 2 diabetes, Testosterone, Hormones, Sex, Sex hormones

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Complications and side effects, Risk factors, COX-2 inhibitors
Similar abstracts:
  • Abstracts: Neurobehavioral effects of dental amalgam in children: A randomized clinical trial. Survival and reasons for failure of amalgam versus composite posterior restorations placed in a randomized clinical trial
  • Abstracts: Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. part 2
  • Abstracts: Attitudes of general dentists regarding the acceptance of gifts and unconventional payments from patients. Changing dentist's knowledge, attitudes and behavior regarding domestic violence through an interactive multimedia tutorial
  • Abstracts: Medical implications of the male biological clock. Disease management and the organization of physician practice
  • Abstracts: Best practices in wound care prevention and treatment. Hospitalists here to stay
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.